Laman Utama600664 • SHA
add
Harbin Pharmaceutical Group Co., Ltd.
Tutup sebelumnya
¥3.64
Julat tahun
¥2.41 - ¥4.13
Permodalan pasaran
9.49B CNY
Bilangan Purata
35.52J
Nisbah P/E
16.19
Hasil dividen
-
Pertukaran utama
SHA
Berita pasaran
Kewangan
Penyata Pendapatan
Hasil
Pendapatan bersih
| (CNY) | Jun 2024info | Perubahan T/T |
|---|---|---|
Hasil | 4.00B | 6.05% |
Perbelanjaan pengendalian | 977.13J | 23.80% |
Pendapatan bersih | 166.64J | 175.81% |
Margin untung bersih | 4.17 | 160.62% |
Pendapatan bagi setiap syer | — | — |
EBITDA | 274.38J | 50.36% |
Kadar cukai berkesan | 22.99% | — |
Kunci Kira-kira
Jumlah aset
Jumlah liabiliti
| (CNY) | Jun 2024info | Perubahan T/T |
|---|---|---|
Pelaburan tunai dan jangka pendek | 3.18B | 22.51% |
Jumlah aset | 14.24B | 3.68% |
Jumlah liabiliti | 8.48B | -0.98% |
Jumlah ekuiti | 5.76B | — |
Syer tertunggak | 2.52B | — |
Harga kepada buku | 1.82 | — |
Pulangan pada aset | 3.80% | — |
Pulangan pada modal | 7.00% | — |
Aliran Tunai
Perubahan bersih dalam tunai
| (CNY) | Jun 2024info | Perubahan T/T |
|---|---|---|
Pendapatan bersih | 166.64J | 175.81% |
Tunai daripada operasi | 344.42J | -1.27% |
Tunai daripada pelaburan | -15.62J | -70.10% |
Tunai daripada pembiayaan | 15.19J | 115.53% |
Perubahan bersih dalam tunai | 344.23J | 40.80% |
Aliran tunai bebas | 377.94J | 6.99% |
Perihal
Harbin Pharmaceutical Group Co., Ltd. is a Chinese partially state-owned company engaged in the research & development, manufacture, and sale of pharmaceutical products. HPGC medication offerings include traditional Chinese medicine and biopharmaceuticals; its main offerings include antibiotics, including amoxicillin and penicillin, and dietary supplements, including zinc gluconate and calcium gluconate.
The company owns both Renmintongtai, a drugstore chain and medical wholesaler for the domestic market, and GNC, a U.S.-based international retailer of supplements and wellness products. Wikipedia
Diasaskan
1988
Tapak web
Pekerja
9,853
